These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8081051)

  • 1. Estimating multiple tumor transition rates based on data from survival-sacrifice experiments.
    Lu Y; Malani HM
    Math Biosci; 1994 Jul; 122(1):95-125. PubMed ID: 8081051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parametric multistate model for the analysis of carcinogenicity experiments.
    Omar RZ; Stallard N; Whitehead J
    Lifetime Data Anal; 1995; 1(4):327-46. PubMed ID: 9385108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling time-to-tumor data: analysis of the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):458-69. PubMed ID: 6642103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multistage prediction of cancer in serially dosed animals with application to the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):470-7. PubMed ID: 6642104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating tumor incidence rates in animal carcinogenicity experiments.
    Dinse GE
    Biometrics; 1988 Jun; 44(2):405-15. PubMed ID: 3390506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiencies of experimental designs for an illness-death model.
    Borgan O; Liestøl K; Ebbesen P
    Biometrics; 1984 Sep; 40(3):627-38. PubMed ID: 6518242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Likelihood function for estimating parameters in multistate disease process with Laplace-transformation-based transition probabilities.
    Lin TY; Yen AM; Chen TH
    Math Biosci; 2021 May; 335():108586. PubMed ID: 33737102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of "safe doses" in carcinogenic experiments.
    Hartley HO; Sielken RL
    Biometrics; 1977 Mar; 33(1):1-30. PubMed ID: 843567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparametric estimation in an "illness-death" model when all transition times are interval censored.
    Frydman H; Gerds T; Grøn R; Keiding N
    Biom J; 2013 Nov; 55(6):823-43. PubMed ID: 24038105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARKOV: a computer program for multi-state Markov models with covariables.
    Marshall G; Guo W; Jones RH
    Comput Methods Programs Biomed; 1995 Jul; 47(2):147-56. PubMed ID: 7587161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds of carcinogenicity in the ED01 study.
    Waddell WJ
    Toxicol Sci; 2003 Mar; 72(1):158-63. PubMed ID: 12604845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.